A Disease Modification Effect of APOE E4 on the Association between Urinary Albumin Excretion and Cognition in Korean Adults

Table 5

Association between cognitive impairment^* and categories of UACR.

Categories of UACR, mg/g	APOE E4 noncarrier		APOE E4 carrier
<15.0	1.00		1.00
15.0–29.9	1.16 (1.00–1.34)	0.052	1.64 (1.19–2.26)	0.002
30.0–299.9	1.31 (1.12–1.52)	0.001	1.26 (0.90–1.76)	0.172
≥300.0	1.87 (1.29–2.72)	0.001	3.56 (1.34–9.42)	0.011
for trend		<0.001		0.024

Odds ratio and 95% confidence intervals are presented.
Adjusted for the same covariates as in Table 2.
^*Cognitive impairment was defined as K-mMMSE lower than 25th percentile according to age, sex, and educational attainments.